Enterprise Value
-164.5M
Cash
303.1M
Avg Qtr Burn
-15.05M
Short % of Float
30.89%
Insider Ownership
36.96%
Institutional Own.
70.11%
Qtr Updated
06/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
DT-216 Details Friedreich’s Ataxia | Phase 1 Data readout |